News & Updates

August 2017: Catabasis Quarterly: Updates on edasalonexent and the MoveDMD Trial

April 2017: Catabasis Quarterly: Updates on edasalonexent and the MoveDMD Trial

February 2017: MoveDMD Part B edasalonexent top line results presentation

February 2017: Catabasis Quarterly: Updates on edasalonexent and the MoveDMD Trial

January 31, 2017: Catabasis Pharmaceuticals Announces Top-Line Results for Part B of the MoveDMD® Trial for Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy

October 2016: Catabasis Quarterly: Updates on the MoveDMD Trial

October 4, 2016: Catabasis Pharmaceuticals Completes Target Enrollment for Part B of the MoveDMD® Trial, a Phase 2 Trial of Edasalonexent (CAT-1004) for the Potential Treatment of Duchenne Muscular Dystrophy

July 2016: Catabasis Quarterly: Updates on the MoveDMD Trial

July 7, 2016: Catabasis Pharmaceuticals Announces the Initiation of an Open-Label Extension for the MoveDMD® Trial Studying Edasalonexent (CAT-1004) in Duchenne Muscular Dystrophy

May 2016: Catabasis Quarterly: Updates on the MoveDMD Trial

April 12, 2016: Catabasis Pharmaceuticals Initiates Part B of the MoveDMDSM Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy

February 5, 2016: Muscular Dystrophy Association to Collaborate with Catabasis Pharmaceuticals on Development of CAT-1004, a Potential Novel Oral Disease-Modifying Treatment for Duchenne Muscular Dystrophy

January 2016: Catabasis Quarterly: Updates on the MoveDMD Trial

January 25, 2016: Catabasis Pharmaceuticals Announces Positive Top-Line Results from Part A of the MoveDMDSM Trial, a Phase 1 / 2 Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy

December 18, 2015: Catabasis Pharmaceuticals Completes Enrollment for Part A of the MoveDMDSM Trial, a Phase 1/2 Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy

October 2015: Catabasis Quarterly: Updates on the MoveDMD Trial

June 17, 2015: Catabasis Pharmaceuticals Initiates MoveDMD, a Phase 1/2 Trial of CAT-1004 for the Treatment of Duchenne Muscular Dystrophy

May 8, 2015: Catabasis Invited to Present in Webinar Hosted by Parent Project Muscular Dystrophy

December 11, 2014: Parent Project Muscular Dystrophy to Collaborate with Catabasis on CAT-1004 Development and Support Subject Travel